Published in Cancer Res on September 01, 1978
Tissue distribution and tumour localization of 99m-technetium-labelled liposomes in cancer patients. Br J Cancer (1979) 1.32
Photochemical release of methotrexate from folate receptor-targeting PAMAM dendrimer nanoconjugate. Photochem Photobiol Sci (2012) 0.91
Suppression of liver uptake of liposomes by dextran sulfate 500. Proc Natl Acad Sci U S A (1983) 0.81
Monoclonal antibody targeting of methotrexate (MTX) against MTX-resistant tumour cell lines. Br J Cancer (1992) 0.75
Identification of a putative second T-cell receptor. Nature (1986) 7.90
Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci U S A (1978) 6.55
Phase transitions in phospholipid vesicles. Fluorescence polarization and permeability measurements concerning the effect of temperature and cholesterol. Biochim Biophys Acta (1973) 4.25
Comparative properties and methods of preparation of lipid vesicles (liposomes). Annu Rev Biophys Bioeng (1980) 4.02
Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev (1999) 4.02
Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res (1994) 3.54
Phospholipid model membranes. I. Structural characteristics of hydrated liquid crystals. Biochim Biophys Acta (1967) 3.29
Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. Biochim Biophys Acta (1979) 3.20
Surface properties of acidic phospholipids: interaction of monolayers and hydrated liquid crystals with uni- and bi-valent metal ions. Biochim Biophys Acta (1968) 3.17
Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci U S A (1988) 2.74
Cochleate lipid cylinders: formation by fusion of unilamellar lipid vesicles. Biochim Biophys Acta (1975) 2.62
Studies on the mechanism of membrane fusion: evidence for an intermembrane Ca2+-phospholipid complex, synergism with Mg2+, and inhibition by spectrin. Biochemistry (1979) 2.46
Phase transitions and phase separations in phospholipid membranes induced by changes in temperature, pH, and concentration of bivalent cations. Biochemistry (1975) 2.34
Local anesthetics affect transmembrane cytoskeletal control of mobility and distribution of cell surface receptors. Proc Natl Acad Sci U S A (1975) 2.26
Introduction of liposome-encapsulated SV40 DNA into cells. J Biol Chem (1980) 2.23
Studies on membrane fusion. III. The role of calcium-induced phase changes. Biochim Biophys Acta (1977) 2.15
Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. Biochim Biophys Acta (1991) 2.08
Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res (1996) 2.07
Studies on the mechanism of membrane fusion: kinetics of calcium ion induced fusion of phosphatidylserine vesicles followed by a new assay for mixing of aqueous vesicle contents. Biochemistry (1980) 2.06
Effects of local anesthetics on membrane properties. I. Changes in the fluidity of phospholipid bilayers. Biochim Biophys Acta (1975) 1.89
Proton-induced fusion of oleic acid-phosphatidylethanolamine liposomes. Biochemistry (1985) 1.88
Studies on the mechanism of action of local anesthetics with phospholipid model membranes. Biochim Biophys Acta (1972) 1.85
Studies on the mechanism of membrane fusion. Role of head-group composition in calcium- and magnesium-induced fusion of mixed phospholipid vesicles. Biochim Biophys Acta (1981) 1.82
Effects of phospholipid acyl chain fluidity, phase transitions, and cholesterol on (Na+ + K+)-stimulated adenosine triphosphatase. J Biol Chem (1974) 1.79
Effects of proteins on thermotropic phase transitions of phospholipid membranes. Biochim Biophys Acta (1975) 1.77
Membrane fusion and molecular segregation in phospholipid vesicles. Biochim Biophys Acta (1974) 1.73
Endocytosis of liposomes and intracellular fate of encapsulated molecules: encounter with a low pH compartment after internalization in coated vesicles. Cell (1983) 1.73
Electron diffraction study of hydrated phospholipid single bilayers. Effects of temperature hydration and surface pressure of the "precursor" monolayer. Biochim Biophys Acta (1975) 1.73
Phospholipid model membranes. II. Permeability properties of hydrated liquid crystals. Biochim Biophys Acta (1967) 1.71
Lipid vesicles as carriers for introducing biologically active materials into cells. Methods Cell Biol (1976) 1.70
Preparation of unilamellar liposomes of intermediate size (0.1-0.2 mumol) by a combination of reverse phase evaporation and extrusion through polycarbonate membranes. Biochim Biophys Acta (1980) 1.66
Liposomes revisited. Science (1995) 1.66
Fusion of mammalian cells by unilamellar lipid vesicles: inflluence of lipid surface charge, fluidity and cholesterol. Biochim Biophys Acta (1973) 1.63
Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice. Cancer Res (1992) 1.62
Calcium/magnesium specificity in membrane fusion: kinetics of aggregation and fusion of phosphatidylserine vesicles and the role of bilayer curvature. Biochemistry (1981) 1.62
Endocytosis and intracellular fate of liposomes using pyranine as a probe. Biochemistry (1990) 1.60
Membrane action of DMSO and other chemical inducers of Friend leukaemic cell differentiation. Nature (1976) 1.59
Biological properties of poliovirus encapsulated in lipid vesicles: antibody resistance and infectivity in virus-resistant cells. Proc Natl Acad Sci U S A (1977) 1.57
Specificity of Ca2+ and Mg2+ binding to phosphatidylserine vesicles and resultant phase changes of bilayer membrane structure. Biochim Biophys Acta (1978) 1.57
Permeability properties of phospholipid membranes: effect of cholesterol and temperature. Biochim Biophys Acta (1972) 1.56
Tumor targeting using anti-her2 immunoliposomes. J Control Release (2001) 1.56
Studies on membrane fusion. II. Induction of fusion in pure phospholipid membranes by calcium ions and other divalent metals. Biochim Biophys Acta (1976) 1.51
Lipid vesicles as carriers for introducing materials into cultured cells: influence of vesicle lipid composition on mechanism(s) of vesicle incorporation into cells. Proc Natl Acad Sci U S A (1976) 1.48
Effects of local anesthetics on membrane properties. II. Enhancement of the susceptibility of mammalian cells to agglutination by plant lectins. Biochim Biophys Acta (1975) 1.46
Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro. Biochemistry (1997) 1.45
Ca2+-induced fusion of phospholipid vesicles monitored by mixing of aqueous contents. Nature (1979) 1.44
Phospholipid requirements for (Na + + K + )-ATPase activity: head-group specificity and fatty acid fluidity. Biochim Biophys Acta (1972) 1.42
Immunoglobulin subclasses in normal children. Pediatr Res (1979) 1.42
Liposome-mediated delivery of deoxyribonucleic acid to cells: enhanced efficiency of delivery related to lipid composition and incubation conditions. Biochemistry (1981) 1.39
Microvascular studies on the origins of perfusion-limited hypoxia. Br J Cancer Suppl (1996) 1.38
Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. Cancer Res (1992) 1.38
Successful treatment with aerosolized pentamidine of Pneumocystis carinii pneumonia in rats. Antimicrob Agents Chemother (1987) 1.35
Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery. FEBS Lett (1997) 1.33
Chondrocyte-derived apoptotic bodies and calcification of articular cartilage. Proc Natl Acad Sci U S A (1998) 1.33
Incorporation of lipid vesicles by mammalian cells provides a potential method for modifying cell behaviour. Nature (1974) 1.33
Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks. Int J Radiat Oncol Biol Phys (1996) 1.32
Role of cholesterol in membranes. Effects on phospholipid-protein interactions, membrane permeability and enzymatic activity. Biochim Biophys Acta (1973) 1.32
Irreversible coupling of immunoglobulin fragments to preformed vesicles. An improved method for liposome targeting. J Biol Chem (1982) 1.32
Evidence for a defect in "switch" T cells in patients with immunodeficiency and hyperimmunoglobulinemia M. N Engl J Med (1986) 1.29
Incorporation of macromolecules within large unilamellar vesicles (LUV). Ann N Y Acad Sci (1978) 1.28
Immunospecific targeting of liposomes to cells: a novel and efficient method for covalent attachment of Fab' fragments via disulfide bonds. Biochemistry (1981) 1.27
Specificity of Na+ binding to phosphatidylserine vesicles from a 23Na NMR relaxation rate study. Biochim Biophys Acta (1979) 1.27
Primary immunodeficiency diseases: an update. Clin Exp Immunol (2003) 1.27
Quantitative analysis of liposome-cell interactions in vitro: rate constants of binding and endocytosis with suspension and adherent J774 cells and human monocytes. Biochemistry (1993) 1.26
Interactions of basic proteins with phospholipid membranes. Binding and changes in the sodium permeability of phosphatidylserine vesicles. J Biol Chem (1971) 1.25
Use of nude mouse xenografts as preclinical drug screens: in vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts. Cancer Treat Rep (1987) 1.25
Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes. Biochim Biophys Acta (1996) 1.25
Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels. Ann Oncol (2008) 1.25
Calcium- and magnesium-induced fusion of mixed phosphatidylserine/phosphatidylcholine vesicles: effect of ion binding. J Membr Biol (1981) 1.24
Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times. J Natl Cancer Inst (1989) 1.23
Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes. Biochim Biophys Acta (1992) 1.22
Mechanism of mononuclear cell activation by an anti-CD43 (sialophorin) agonistic antibody. J Immunol (1989) 1.21
Identification of a closely linked DNA marker, DXS178, to further refine the X-linked agammaglobulinemia locus. Genomics (1990) 1.21
Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. J Clin Oncol (2001) 1.18
Control of membrane fusion by phospholipid head groups. I. Phosphatidate/phosphatidylinositol specificity. Biochim Biophys Acta (1981) 1.17
pH-sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules. FEBS Lett (1985) 1.16
Endocytosis of liposomes by macrophages: binding, acidification and leakage of liposomes monitored by a new fluorescence assay. Biochim Biophys Acta (1990) 1.14
Recognition of liposomes by cells: in vitro binding and endocytosis mediated by specific lipid headgroups and surface charge density. Biochim Biophys Acta (1992) 1.14
The role of surface charge and hydrophilic groups on liposome clearance in vivo. Biochim Biophys Acta (1992) 1.13
Inhibition of tumor cell growth in vitro and in vivo by 1-beta-D-arabinofuranosylcytosine entrapped within phospholipid vesicles. Cancer Res (1976) 1.12
Stability of asymmetric phospholipid membranes. Science (1969) 1.12
Liquid diffraction analysis of the model membrane system. Egg lecithin + myelin protein (N-2). Biophys J (1979) 1.12
Polyamines as modulators of membrane fusion: aggregation and fusion of liposomes. Biochemistry (1983) 1.12
Liposome-mediated delivery of tobacco mosaic virus RNA into tobacco protoplasts: A sensitive assay for monitoring liposome-protoplast interactions. Proc Natl Acad Sci U S A (1982) 1.11
Liposomes: the development of a new carrier system for introducing nucleic acid into plant and animal cells. Curr Top Microbiol Immunol (1982) 1.11
Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies. Cancer Res (1990) 1.10
Role of synexin in membrane fusion. Enhancement of calcium-dependent fusion of phospholipid vesicles. J Biol Chem (1981) 1.10
Synexin-like proteins from human polymorphonuclear leukocytes. Identification and characterization of granule-aggregating and membrane-fusing activities. J Biol Chem (1987) 1.08
Cellular uptake of cyclic AMP captured within phospholipid vesicles and effect on cell-growth behaviour. Biochim Biophys Acta (1974) 1.08
Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes. Cancer Res (1994) 1.08
Liposomes with detachable polymer coating: destabilization and fusion of dioleoylphosphatidylethanolamine vesicles triggered by cleavage of surface-grafted poly(ethylene glycol). FEBS Lett (1996) 1.08
Liposome preparation and size characterization. Methods Enzymol (1989) 1.07
Long circulating liposomes encapsulating organophosphorus acid anhydrolase in diisopropylfluorophosphate antagonism. Toxicol Sci (2000) 1.07
Sterically stabilized liposomes. Reduction in electrophoretic mobility but not electrostatic surface potential. Biophys J (1992) 1.07
Biophysical properties of phospholipids. II. Permeability of phosphatidylserine liquid crystals to univalent ions. Biochim Biophys Acta (1966) 1.06
Na + -K + discrimination by "pure" phospholipid membranes. Biochim Biophys Acta (1971) 1.06
Antibody-targeted liposomes: increase in specific toxicity of methotrexate-gamma-aspartate. Proc Natl Acad Sci U S A (1983) 1.06
Control of membrane fusion by phospholipid head groups. II. The role of phosphatidylethanolamine in mixtures with phosphatidate and phosphatidylinositol. Biochim Biophys Acta (1981) 1.06
Lipid mixing during membrane aggregation and fusion: why fusion assays disagree. Biochemistry (1987) 1.06